DEFINITIVE PROXY STATEMENT

Company

Lineage Cell Therapeutics, Inc.

Filed

April 30, 2010

Period of Report

June 10, 2010

Accession Number

0001206774-10-001133

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →